Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novo Nordisk awaiting FDA comment on diabetes drug
Novo Nordisk awaiting FDA comment on diabetes drug
Novo Nordisk awaiting FDA comment on diabetes drug
Submitted by
admin
on December 30, 2009 - 9:16am
Source:
Marketwatch
News Tags:
Novo Nordisk
FDA
diabetes
liraglutide
Headline:
Novo Nordisk awaiting FDA comment on diabetes drug
Do Not Allow Advertisers to Use My Personal information
